AmBisome is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Amphotericin B.
Product ID | 0469-3051_5f3f2915-440e-4faa-9e4d-71efae2f50e8 |
NDC | 0469-3051 |
Product Type | Human Prescription Drug |
Proprietary Name | AmBisome |
Generic Name | Amphotericin B |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 1997-08-11 |
Marketing Category | NDA / NDA |
Application Number | NDA050740 |
Labeler Name | Astellas Pharma US, Inc. |
Substance Name | AMPHOTERICIN B |
Active Ingredient Strength | 50 mg/12.5mL |
Pharm Classes | Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1997-08-11 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA050740 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1997-08-11 |
Ingredient | Strength |
---|---|
AMPHOTERICIN B | 50 mg/12.5mL |
SPL SET ID: | f7be6506-4d20-401e-a0ff-02ad7c33158a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0469-3051 | AmBisome | amphotericin B |
39822-1055 | Amphotericin B | Amphotericin B |
55150-365 | Amphotericin B | Amphotericin B |
62756-233 | Amphotericin B | Amphotericin B |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AMBISOME 88849383 not registered Live/Pending |
Gilead Sciences, Inc. 2020-03-26 |
AMBISOME 73814641 1598121 Live/Registered |
VESTAR, INC. 1989-07-24 |